Mini Quiz: Treatment-Induced Neuropathy of Diabetes

What are the key symptoms of TIND, a rare condition that can occur after rapid normalization of blood glucose levels following prolonged periods of hyperglycemia?

Symptoms of treatment-induced neuropathy of diabetes include all of the following EXCEPT:

A. Syncope
B. Worsening retinopathy
C. Hearing loss
D. Burning/shooting pain in the lower extremities
Related Videos
Related Content

How Once-Nightly Sodium Oxybate Changes the Treatment Landscape for Narcolepsy

June 9th 2023

Episode 90: Raising Stroke Awareness and Improving Clinical Care

June 2nd 2023

Phase 2/3 Study of Blarcamesine in Pediatrics With Rett Syndrome Completes Enrollment

June 8th 2023

Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates

May 31st 2023

RESTORE Analysis Shows Significant Patient Preference to Once-Nightly Sodium Oxybate Over Twice-Nightly

June 8th 2023

FibroGen's Duchenne Muscular Dystrophy Antibody Pamrevlumab Falls Short in Phase 3

June 7th 2023

How Once-Nightly Sodium Oxybate Changes the Treatment Landscape for Narcolepsy

June 9th 2023

Episode 90: Raising Stroke Awareness and Improving Clinical Care

June 2nd 2023

Phase 2/3 Study of Blarcamesine in Pediatrics With Rett Syndrome Completes Enrollment

June 8th 2023

Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates

May 31st 2023

RESTORE Analysis Shows Significant Patient Preference to Once-Nightly Sodium Oxybate Over Twice-Nightly

June 8th 2023

FibroGen's Duchenne Muscular Dystrophy Antibody Pamrevlumab Falls Short in Phase 3

June 7th 2023

How Once-Nightly Sodium Oxybate Changes the Treatment Landscape for Narcolepsy

June 9th 2023

Episode 90: Raising Stroke Awareness and Improving Clinical Care

June 2nd 2023

Phase 2/3 Study of Blarcamesine in Pediatrics With Rett Syndrome Completes Enrollment

June 8th 2023

Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates

May 31st 2023

RESTORE Analysis Shows Significant Patient Preference to Once-Nightly Sodium Oxybate Over Twice-Nightly

June 8th 2023

FibroGen's Duchenne Muscular Dystrophy Antibody Pamrevlumab Falls Short in Phase 3

June 7th 2023
© 2023 MJH Life Sciences

All rights reserved.